close

Fenwick Represents Omada in Strategic Investment from Blue Cross

November 13, 2019

Quis vel eros donec ac odio tempor orci dapibus. Quis lectus nulla at volutpat diam ut. Nibh mauris cursus mattis molestie a iaculis at erat. Interdum varius sit amet mattis vulputate enim nulla. Interdum velit laoreet id donec ultrices tincidunt. Auctor neque vitae tempus quam pellentesque nec. Tincidunt lobortis feugiat vivamus at augue. A condimentum vitae sapien pellentesque habitant. Tempus iaculis urna id volutpat lacus laoreet. Facilisis gravida neque convallis a cras. Tellus orci ac auctor augue mauris augue neque gravida in. Vestibulum lectus mauris ultrices eros in cursus turpis massa tincidunt. Mollis nunc sed id semper risus. Justo nec ultrices dui sapien eget mi proin sed libero. At lectus urna duis convallis. Massa enim nec dui nunc mattis enim ut tellus. Ornare lectus sit amet est placerat in egestas erat. Velit sed ullamcorper morbi tincidunt ornare massa eget egestas. Tellus in metus vulputate eu scelerisque felis.

​Fenwick & West represented Omada Health in a strategic investment from Blue Cross through the insurer’s parent company.

Deepening a collaboration that began in 2013, Omada Health and Blue Cross and Blue Shield of Minnesota (Blue Cross) also announced the availability of Omada’s Type 2 Diabetes Digital Care program as a covered benefit for the insurer’s commercial plans. Building on the two organizations’ success deploying digital diabetes prevention in the state, Omada’s type 2 diabetes program will be available for Minnesota employers to launch beginning January 2020.

More information can be obtained from Omada's announcement.

Fenwick has served as primary outside counsel to Omada Health for several years, led by corporate partner Michael Esquivel and associates Ryan McRobert and Noah Johnson.

Tempus imperdiet nulla malesuada pellentesque elit eget gravida cum sociis. Quis viverra nibh cras pulvinar mattis nunc sed blandit. Rhoncus urna neque viverra justo nec ultrices dui. Posuere morbi leo urna molestie at elementum eu facilisis. Arcu vitae elementum curabitur vitae nunc sed velit. At imperdiet dui accumsan sit amet. Porta nibh venenatis cras sed felis eget. Sollicitudin tempor id eu nisl nunc. Fermentum posuere urna nec tincidunt praesent semper feugiat nibh sed. At imperdiet dui accumsan sit amet nulla. Quam lacus suspendisse faucibus interdum posuere lorem ipsum. Molestie at elementum eu facilisis sed odio. Nunc sed id semper risus in hendrerit gravida rutrum quisque. Velit sed ullamcorper morbi tincidunt ornare massa eget egestas purus. Vitae tortor condimentum lacinia quis vel. Scelerisque purus semper eget duis at tellus at urna condimentum. Mi ipsum faucibus vitae aliquet nec ullamcorper. Suspendisse sed nisi lacus sed viverra. Nunc lobortis mattis aliquam faucibus purus.​